Aller au contenu principal
Profil bibliographique

Rickard S. Nyman

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

74Publications signalées
2224Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Hepatocellular Carcinoma Treatment and PrognosisLiver Disease and TransplantationAortic aneurysm repair treatmentsAortic Disease and Treatment ApproachesOrgan Transplantation Techniques and Outcomes

Les publications récentes

Accès ouvert 2023 article OpenAlex

A randomized trial comparing percutaneous endoscopic gastrostomy (PEG) and radiologically inserted percutaneous gastrostomy (RIG)

Magnus Sundbom, Eladio Cabrera, Rickard S. Nyman, Charlotte Ebeling Barbier et autres

BACKGROUND AND OBJECTIVE: At present, percutaneous endoscopic gastrostomy (PEG) is the procedure of choice in establishing a permanent feeding tube in patients with chronic severe dysphagia. This is the first prospective randomized study in adults comparing PEG with radiologically inserted gastrostomy (RIG). …

se (code pays fourni par la source)

11 citations Scandinavian Journal of Surgery
Accès ouvert 2022 article OpenAlex

Study protocol for locoregional precision treatment of hepatocellular carcinoma with transarterial chemoembolisation (TACTida), a clinical study: idarubicin dose selection, tissue response and survival

Sofi Sennefelt Nyman, Håkan K. Ahlström, Angeliki Dimopoulou Creusen, David Dahlgren et autres

INTRODUCTION: Hepatocellular carcinoma (HCC) is a common cause of cancer-related death, often detected in the intermediate stage. The standard of care for intermediate-stage HCC is transarterial chemoembolisation (TACE), where idarubicin (IDA) is a promising drug. Despite the fact that TACE has been …

se, dk (code pays fourni par la source)

9 citations BMJ Open
Accès ouvert 2020 article OpenAlex

Placement of a transjugular intrahepatic portosystemic shunt in addition to recanalization of acute and chronic portomesenteric vein occlusions – a retrospective evaluation

Charlotte Ebeling Barbier, Fredrik Rorsman, Lars‐Gunnar Eriksson, Per Sangfelt et autres

Background Portomesenteric vein thrombosis may be life-threatening due to bowel ischemia caused by venous stasis, or variceal bleeding caused by portal hypertension. Purpose To evaluate the effectiveness and safety of recanalization combined with transjugular intrahepatic portosystemic shunt in acute and chronic portomesenteric …

se (code pays fourni par la source)

8 citations Acta Radiologica Open
2020 article OpenAlex

Portal vein embolization with n-butyl-cyanoacrylate before hepatectomy: a single-center retrospective analysis of 46 consecutive patients

Marijela Moreno Berggren, Bengt Isaksson, Rickard S. Nyman, Charlotte Ebeling Barbier

BACKGROUND: Preoperative portal vein embolization (PVE) is performed to induce hypertrophy of the future liver remnant enabling major liver resection in patients with various types of liver tumors. PURPOSE: To evaluate safety and effectiveness of PVE with n-butyl-cyanoacrylate (NBCA). MATERIAL AND METHODS: …

se (code pays fourni par la source)

3 citations Acta Radiologica
2017 article OpenAlex

Treatment of acute portomesenteric venous thrombosis with thrombectomy through a transjugular intrahepatic portosystemic shunt: a single-center experience

Kerstin Rosenqvist, Charlotte Ebeling Barbier, Fredrik Rorsman, Per Sangfelt et autres

Background Acute portomesenteric venous thrombosis (PMVT) is a potentially life-threatening condition and urgent treatment is required. Purpose To retrospectively evaluate the efficacy and safety of treating acute PMVT by the creation of a transjugular intrahepatic portosystemic shunt (TIPS) followed by thrombectomy. Material …

se (code pays fourni par la source)

18 citations Acta Radiologica
2017 letter OpenAlex

Reply to “Comment on ‘In Vivo Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular Carcinoma’”

Ilse R. Dubbelboer, Elsa Lilienberg, Amar Karalli, Rimma Axelsson et autres

ADVERTISEMENT RETURN TO ISSUEPREVCommunicationNEXTReply to "Comment on 'In Vivo Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular Carcinoma'"Ilse R. Dubbelboer†, Elsa Lilienberg†, Amar Karalli‡§, Rimma Axelsson‡§, Torkel B. Brismar‡§, Charlotte Ebeling Barbier∥, Agneta Norén⊥, Frans Duraj⊥, Mikael …

se (code pays fourni par la source)

1 citation Molecular Pharmaceutics
2017 article OpenAlex

Repeated thrombectomy through a transjugular intrahepatic portosystemic shunt. An effective and safe way to treat acute portomesenteric venous thrombosis.

Kerstin Rosenqvist, Charlotte Ebeling Barbier, Fredrik Rorsman, Per Sangfelt et autres

Portal hypertension (PHT) is a condition with serious complications, such as variceal bleeding, refractory ascites and bowel ischemia. The cause of PHT may be pre-, intra- or post-hepatic. Initial treatment is pressure-reducing drugs and the treatment of acute symptoms.Ten patients presented with …

0 citations
2016 article OpenAlex

In Vivo Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular Carcinoma

Elsa Lilienberg, Ilse R. Dubbelboer, Amar Karalli, Rimma Axelsson et autres

Doxorubicin (DOX) delivered in a lipiodol-based emulsion (LIPDOX) or in drug-eluting beads (DEBDOX) is used as palliative treatment in patients with intermediate-stage hepatocellular carcinoma (HCC). The primary objective of this study was to evaluate the in vivo delivery performance of DOX from …

se (code pays fourni par la source)

41 citations Molecular Pharmaceutics
2016 article OpenAlex

Endovascular treatment of symptomatic Budd–Chiari syndrome – in favour of early transjugular intrahepatic portosystemic shunt

Kerstin Rosenqvist, Reza Sheikhi, Lars‐Gunnar Eriksson, Rupesh Rajani et autres

INTRODUCTION: Treatment of Budd-Chiari syndrome (BCS) has shifted from mainly medical treatment, with surgical shunt and orthotopic liver transplantation (OLT) as rescue, to medical treatment combined with an early endovascular intervention in the past two decades. PURPOSE: To assess the safety and …

se, us (code pays fourni par la source)

37 citations European Journal of Gastroenterology & Hepatology
2015 article OpenAlex

Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver

Kerstin Rosenqvist, Lars‐Gunnar Eriksson, Fredrik Rorsman, Per Sangfelt et autres

BACKGROUND: Treatment of patients with portal vein thrombosis (PVT) differs due to different etiology and wide range of symptoms but certain patients seems to benefit from endovascular intervention. PURPOSE: To assess the safety and efficiency of endovascular treatment of acute and chronic …

se (code pays fourni par la source)

53 citations Acta Radiologica

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.